XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Treasury Stock
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Mar. 31, 2020   135,927   (22,421)    
Beginning balance at Mar. 31, 2020 $ 2,539,244 $ 1,359 $ 2,134,748 $ (820,572) $ 1,282,085 $ (58,376)
Increase (Decrease) in Stockholders' Equity            
Net income 370,074       370,074  
Change in cumulative foreign currency translation adjustment 53,697         53,697
Change in gains on cash flow hedge, net (4,905)         (4,905)
Net unrealized gain on available-for-sale securities, net of taxes 4,000         4,000
Stock-based compensation 141,904   141,904      
Issuance of restricted stock, net of forfeitures and cancellations (in shares)   1,235        
Issuance of restricted stock, net of forfeitures and cancellations 1 $ 13 (12)      
Net share settlement of restricted stock awards (in shares)   (401)        
Net share settlement of restricted stock awards (60,586) $ (5) (60,581)      
Employee share purchase plan settlement (in shares)   139        
Employee share purchase plan settlement 14,215 $ 2 14,213      
Issuance of shares related to acquisition (in shares)   604        
Issuance of shares related to acquisition 97,647 $ 6 97,641      
Ending balance (in shares) at Dec. 31, 2020   137,504   (22,421)    
Ending balance at Dec. 31, 2020 3,155,291 $ 1,375 2,327,913 $ (820,572) 1,652,159 (5,584)
Beginning balance (in shares) at Sep. 30, 2020   137,349   (22,421)    
Beginning balance at Sep. 30, 2020 2,901,282 $ 1,373 2,285,394 $ (820,572) 1,469,911 (34,824)
Increase (Decrease) in Stockholders' Equity            
Net income 182,248       182,248  
Change in cumulative foreign currency translation adjustment 30,135         30,135
Change in gains on cash flow hedge, net (600)         (600)
Net unrealized gain on available-for-sale securities, net of taxes (295)         (295)
Stock-based compensation 47,192   47,192      
Issuance of restricted stock, net of forfeitures and cancellations (in shares)   141        
Issuance of restricted stock, net of forfeitures and cancellations 1 $ 2 (1)      
Net share settlement of restricted stock awards (in shares)   (60)        
Net share settlement of restricted stock awards (12,384) $ (1) (12,383)      
Employee share purchase plan settlement (in shares)   74        
Employee share purchase plan settlement 7,712 $ 1 7,711      
Ending balance (in shares) at Dec. 31, 2020   137,504   (22,421)    
Ending balance at Dec. 31, 2020 3,155,291 $ 1,375 2,327,913 $ (820,572) 1,652,159 (5,584)
Beginning balance (in shares) at Mar. 31, 2021   137,584   (22,421)    
Beginning balance at Mar. 31, 2021 3,331,892 $ 1,376 2,288,781 $ (820,572) 1,870,971 (8,664)
Increase (Decrease) in Stockholders' Equity            
Net income 307,050       307,050  
Change in cumulative foreign currency translation adjustment (24,096)         (24,096)
Net unrealized gain on available-for-sale securities, net of taxes (1,823)         (1,823)
Stock-based compensation 198,045   198,045      
Repurchased common stock (in shares)       (1,260)    
Repurchased common stock (200,012)     $ (200,012)    
Issuance of restricted stock, net of forfeitures and cancellations (in shares)   1,096        
Issuance of restricted stock, net of forfeitures and cancellations 0 $ 11 (11)      
Net share settlement of restricted stock awards (in shares)   (330)        
Net share settlement of restricted stock awards (59,131) $ (3) (59,128)      
Employee share purchase plan settlement (in shares)   142        
Employee share purchase plan settlement 19,658 $ 2 19,656      
Issuance of shares related to acquisition (in shares)   515        
Issuance of shares related to acquisition 94,154 $ 5 94,149      
Ending balance (in shares) at Dec. 31, 2021   139,007   (23,681)    
Ending balance at Dec. 31, 2021 3,665,737 $ 1,391 2,541,492 $ (1,020,584) 2,178,021 (34,583)
Beginning balance (in shares) at Sep. 30, 2021   138,891   (23,681)    
Beginning balance at Sep. 30, 2021 3,469,668 $ 1,390 2,475,085 $ (1,020,584) 2,033,524 (19,747)
Increase (Decrease) in Stockholders' Equity            
Net income 144,497       144,497  
Change in cumulative foreign currency translation adjustment (13,497)         (13,497)
Net unrealized gain on available-for-sale securities, net of taxes (1,339)         (1,339)
Stock-based compensation 61,741   61,741      
Issuance of restricted stock, net of forfeitures and cancellations (in shares)   76        
Issuance of restricted stock, net of forfeitures and cancellations 0 $ 1 (1)      
Net share settlement of restricted stock awards (in shares)   (32)        
Net share settlement of restricted stock awards (5,761) $ (1) (5,760)      
Employee share purchase plan settlement (in shares)   72        
Employee share purchase plan settlement 10,428 $ 1 10,427      
Ending balance (in shares) at Dec. 31, 2021   139,007   (23,681)    
Ending balance at Dec. 31, 2021 $ 3,665,737 $ 1,391 $ 2,541,492 $ (1,020,584) $ 2,178,021 $ (34,583)